Organon & Co.
OGNNYSEHealthcare● Active
$13.36
$-0.04(-0.30%)
Market Cap$3.5B
P/E Ratio—
52W High$13.48
52W Low$5.69
Organon & Co. (OGN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OGN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B |
| Cost of Revenue | $2.85B | $2.69B | $2.52B | $2.29B | $2.38B |
| Gross Profit | $3.36B | $3.71B | $3.75B | $3.88B | $3.92B |
| Gross Margin %(computed) | 54.09% | 58.02% | 59.84% | 62.84% | 62.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.37B | $0.47B | $0.53B | $0.47B | $0.44B |
| G&A Expenses | $0.00B | $1.55B | $1.68B | $1.45B | $1.43B |
| Total Operating Expenses | $2.09B | $2.23B | $2.42B | $2.17B | $2.01B |
| Operating Income | $1.28B | $1.49B | $1.33B | $1.71B | $1.92B |
| Operating Margin %(computed) | 20.67% | 23.21% | 21.19% | 27.62% | 30.38% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.50B | $0.52B | $0.53B | $0.42B | $0.26B |
| Income Before Tax | $0.42B | $0.81B | $0.67B | $1.12B | $1.53B |
| Income Tax Expense | $0.24B | ($0.06B) | ($0.35B) | $0.20B | $0.18B |
| Net Income | $0.19B | $0.86B | $1.02B | $0.92B | $1.35B |
| Net Margin %(computed) | 3.01% | 13.49% | 16.33% | 14.85% | 21.43% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.72 | $3.36 | $4.01 | $3.61 | $5.33 |
| Wtd Avg Shares | 0.26B | 0.26B | 0.26B | 0.25B | 0.25B |
| EBITDA | $1.28B | $1.60B | $1.44B | $1.76B | $1.98B |
| EBITDA Margin %(computed) | 20.63% | 25.05% | 22.93% | 28.44% | 31.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Organon & Co. data
About Organon & Co. (OGN) Income Statement
Organon & Co. (OGN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OGN reported revenue of $6.22B, gross profit of $3.36B (gross margin 54.09%), and net income of $0.19B — a net profit margin of 3.01%.
Frequently asked questions
OGN · 4 questionsOrganon & Co. (OGN) reported revenue of $6.22B for 2025, down 2.9% year-over-year.
OGN revenueOGN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08